Genmont Biotech Inc operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genmont Biotech Inc with three other
companies in this sector in TAIWAN :
Mycenax Biotech Incorporated
sales of 390.84 million Taiwanese Dollars [US$13.30 million]
of which 99%
was Technical Service Income),
(476.09 million Taiwanese Dollars [US$16.20 million]
of which 100%
was Antibody and Protein Medicine Developmen), and
Abnova (Taiwan) Corporation
(414.16 million Taiwanese Dollars [US$14.09 million]
of which 31%
was Monoclonal Antibodies).
Genmont Biotech Inc reported sales of 346.24 million Taiwanese Dollars (US$11.78 million)
December of 2019.
decrease of 14.8%
versus 2018, when the company's sales were 406.53 million Taiwanese Dollars .